وطن نيوز
“,”heading”:””,”fullWindow”:false,”fullBleed”:false,”showFullBleedOnMobile”:false,”headColor”:””,”type”:”html5mobile”,”textColor”:””,”mobileImageUrl”:””,”bgColor”:””,”imageUrl”:””,”registeredOnly”:false,”linkUrl”:””,”aodaTitle”:”Graphic for Andrew Peller Ltd.”,”internalScroll”:false,”displayStyle”:”small-up”},{“text”:”George Weston Ltd. (WN)“,”type”:”text”,”isParagraph”:true},{“text”:”The company behind the Loblaw empire announced this week it was looking to sell off its bakery division. The company also unveiled an executive suite reshuffling, announcing that Galen G. Weston will take over as chairman and president of the Loblaws grocery chain in early May, when current president Sarah Davis retires. Late last year, Weston also took over as controlling shareholder of Wittington Investments Ltd., the family’s holding company, succeeding his father W. Galen Weston.”,”type”:”text”,”isParagraph”:true},{“type”:”textBreakPoint”,”insertAt”:”contentMiddleBreakPoint”},{“snippet”:”n”,”heading”:””,”fullWindow”:false,”fullBleed”:false,”showFullBleedOnMobile”:false,”headColor”:””,”type”:”html5mobile”,”textColor”:””,”mobileImageUrl”:””,”bgColor”:””,”imageUrl”:””,”registeredOnly”:false,”linkUrl”:””,”aodaTitle”:”Graphic for George Weston Ltd.”,”internalScroll”:false,”displayStyle”:”small-up”},{“text”:”Helius Medical Technologies (HSM)“,”type”:”text”,”isParagraph”:true},{“text”:”The little-known Pennsylvania-based company, which trades on the TSX, announced last week that its Portable Neuromodulation Stimulator has received marketing approval by the U.S. Food and Drug Administration. The PoNS is designed to help multiple sclerosis patients with their gait, and has also been used to help patients with mild to moderate brain injuries maintain their balance. It’s Helius’s only commercially available product, and has already been approved for use in Canada.”,”type”:”text”,”isParagraph”:true},{“snippet”:”n”,”heading”:””,”fullWindow”:false,”fullBleed”:false,”showFullBleedOnMobile”:false,”headColor”:””,”type”:”html5mobile”,”textColor”:””,”mobileImageUrl”:””,”bgColor”:””,”imageUrl”:””,”registeredOnly”:false,”linkUrl”:””,”aodaTitle”:”Graphic for Helius Medical Technologies “,”internalScroll”:false,”displayStyle”:”small-up”},{“type”:”ad”,”heading”:”ARTICLE CONTINUES BELOW”,”name”:”ArticleSecondBigBox”,”display”:”medium-down”,”pos”:”2″,”interstitial”:true,”sizes”:[[300,250]]},{“text”:”LOSERS“,”type”:”text”,”isParagraph”:true},{“text”:”Canaccord Genuity Group Inc.: Canaccord revealed last week that it had made a $367-million bid for fellow wealth management firm RF Capital Group, a move that was rejected out of hand by RF Capital’s board of directors and its biggest shareholder. That shareholder, Richardson Financial Group Ltd., wouldn’t even meet to discuss the offer, according to Canaccord. The takeover would have brought two of Canada’s biggest independent wealth management firms under the same roof.”,”type”:”text”,”isParagraph”:true},{“snippet”:”n”,”heading”:””,”fullWindow”:false,”fullBleed”:false,”showFullBleedOnMobile”:false,”headColor”:””,”type”:”html5mobile”,”textColor”:””,”mobileImageUrl”:””,”bgColor”:””,”imageUrl”:””,”registeredOnly”:false,”linkUrl”:””,”aodaTitle”:”Graphic for Canaccord Genuity Group Inc.”,”internalScroll”:false,”displayStyle”:”small-up”},{“text”:”Riv Capital Inc. (RIV)“,”type”:”text”,”isParagraph”:true},{“type”:”relatedStories”,”relatedStories”:[]},{“text”:”Pity poor Riv. Ever since a deal to cut ties with its former parent company (licensed cannabis producer Canopy Growth) closed in late February, Riv’s shares have been mired in the doldrums. The cannabis-focused venture capital firm, which already has stakes in 13 different companies, has announced it will be pursuing more investments in the U.S. Riv is also one of several companies being sued for $500 million by a former partner in PharmHouse, a cannabis-growing joint venture that sought protection from creditors last year.”,”type”:”text”,”isParagraph”:true},{“snippet”:”n”,”heading”:””,”fullWindow”:false,”fullBleed”:false,”showFullBleedOnMobile”:false,”headColor”:””,”type”:”html5mobile”,”textColor”:””,”mobileImageUrl”:””,”bgColor”:””,”imageUrl”:””,”registeredOnly”:false,”linkUrl”:””,”aodaTitle”:”Graphic for Riv”,”internalScroll”:false,”displayStyle”:”small-up”},{“text”:”CP Rail (CP)“,”type”:”text”,”isParagraph”:true},{“type”:”slimcut”},{“type”:”textBreakPoint”,”insertAt”:”contentEndBreakPoint”},{“text”:”CP’s proposed takeover of U.S. rail firm Kansas City Southern would give the combined company a 37,000-kilometre network that ranges from Canada to Mexico. But the $25 billion (U.S.) deal could still get kiboshed by U.S. regulators, who haven’t approved a rail merger in 20 years. CP Rail investors could also be forgiven for being concerned about the company’s already sky-high debt ratio, which could climb even higher if the deal is approved. “,”type”:”text”,”isParagraph”:true},{“type”:”cta”,”buttonText”:”Sign Up Now”,”buttonLink”:”/emails.html?nsrc=article-inline-business”,”description”:”Read the business news and analysis that matters most every morning, including the latest on what the coronavirus means for you, in our Star Business email newsletter.”,”title”:”Get more business in your inbox”},{“snippet”:”n”,”heading”:””,”fullWindow”:false,”fullBleed”:false,”showFullBleedOnMobile”:false,”headColor”:””,”type”:”html5mobile”,”textColor”:””,”mobileImageUrl”:””,”bgColor”:””,”imageUrl”:””,”registeredOnly”:false,”linkUrl”:””,”aodaTitle”:”Graphic for CP Rail”,”internalScroll”:false,”displayStyle”:”small-up”},{“text”:”Josh Rubin is a Toronto-based business reporter.”,”author”:{“janrainUuid”:”2d1f9caf-acb1-4045-88f6-2d46c83d4983″,”author”:”Josh Rubin”,”facebookmeta”:”https://www.facebook.com/pages/Josh-Rubin/234914459966218″,”photo”:{“origImageSize”:”800×500″,”lastmodified”:2700061000,”url”:”/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”,”sizes”:{“1:1”:{“small”:”https://w6nnews.com/wp-content/uploads/2021/03/1616280733_270_The-Faceoff-Online-shopping-struggle-—-Shopify-is-luring-businesses.jpg”},”3:2″:{“small”:”https://images.thestar.com/nhAmckWnBcS988bkCf5BJKWX4nw=/114×76/smart/https://www.thestar.com/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”,”medium”:”https://images.thestar.com/VUGML7cxntQPnSJZYcLpzu9Q4OQ=/330×220/smart/https://www.thestar.com/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”,”large”:”https://images.thestar.com/iAjJqpo7K5ovzHFlQPEDHqFCmPg=/690×460/smart/https://www.thestar.com/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”},”21:9″:{“large”:”https://images.thestar.com/bgftfWvkqliNGkLDyB_LBeM_AVk=/1080×460/smart/https://www.thestar.com/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”}}},”location”:”Toronto”,”tag”:”josh_rubin”,”credit”:”Business Reporter”,”twitterId”:”starbeer”,”email”:”josh@thestar.ca”},”authorPageUrl”:”https://www.thestar.com/authors.josh_rubin.html”,”type”:”endnote”,”isLast”:true},{“type”:”shareBar”},{“type”:”trustbar”}],”assetTags”:[“stocks”,”itc1″,”winners_and_losers”,”george_weston_limited”,”s_p_tsx_60″,”genuity”,”finance”,”smg_business”,”opinion”,”josh_rubin”,”economy_of_canada”,”kmi2″,”InHouseArticle_thestar”,”companies”,”canopy_growth”,”canaccord_genuity”],”seoKeywords”:”Opinion,stocks,Winners and Losers,ITC1,KMI2,smg_business,InHouseArticle_thestar”,”excludeInRecommendations”:false,”promo”:[],”related”:{“pubdays”:0,”strategy”:0},”personalizationMetadata”:{“inHouseArticle”:”true”,”image”:”https://images.thestar.com/B694jtcqkQ1KIqVstjF7kGQq-2E=/1280×1024/smart/filters:cb(1617020766159)/https://www.thestar.com/content/dam/thestar/business/2021/03/29/helius-medical-technologies-gets-boost-after-securing-fda-approval-while-cp-rail-drops-amid-takeover-offer-for-kansas-city-southern/woman_with_walker.jpg”,”enableLivechat”:”false”,”images”:”https://www.thestar.com/assets/img/thestar-ribbon.png”,”noShow”:”false”,”enableConversations”:”false”,”description”:”Stock surges and setback for the week ending March 26″,”hasImage”:true,”section”:”Business”,”abstract”:”Stock surges and setback for the week ending March 26″,”asset_id”:”accc43f3-c1ae-40fb-b32d-224b1544ef4c”,”title”:”Helius Medical Technologies gets boost after securing FDA approval while CP Rail drops amid takeover offer for Kansas City Southern”,”type”:”article”,”smg_tag”:”business”,”url”:”https://www.thestar.com/business/2021/03/29/helius-medical-technologies-gets-boost-after-securing-fda-approval-while-cp-rail-drops-amid-takeover-offer-for-kansas-city-southern.html”,”site_name”:”thestar.com”,”enableLivechatadmin”:”false”,”thumbor_image”:”{“imageid”:”G0716FVBL.3″,”origImageSize”:”1200×801″,”lastmodified”:1616796441384,”fullWindowMainart”:false,”forceoriginal”:false,”caption”:”Helius Medical Technologies had success this week after it was announced that its Portable Neuromodulation Stimulator, designed to help multiple sclerosis patients with their gait, received marketing approval by the U.S. Food and Drug Administration. It is already been approved for use in Canada.”,”source”:”Dreamstime”,”type”:”image”,”credit”:””,”mainartSize”:”medium”,”url”:”/content/dam/thestar/business/2021/03/29/helius-medical-technologies-gets-boost-after-securing-fda-approval-while-cp-rail-drops-amid-takeover-offer-for-kansas-city-southern/woman_with_walker.jpg”}”,”published_time”:”2021-03-29T11:00:00Z”,”publisher”:”https://www.facebook.com/torontostar”,”last_modified”:”2021-03-27T23:02:09.028Z”,”author_names”:[“Josh Rubin”],”authors”:”[{“author”:”Josh Rubin”,”photo”:{“origImageSize”:”800×500″,”lastmodified”:2700061000,”url”:”/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”}}]”},”seoHead”:”Helius Medical Technologies gets boost after securing FDA approval while CP Rail drops amid takeover offer for Kansas City Southern”,”chevronTextBGColor”:”009988″,”headline”:”Helius Medical Technologies gets boost after securing FDA approval while CP Rail drops amid takeover offer for Kansas City Southern”,”subheadline”:”Stock surges and setback for the week ending March 26″,”removeInterestedInFlag”:true,”canonicalUrl”:”https://www.thestar.com/business/2021/03/29/helius-medical-technologies-gets-boost-after-securing-fda-approval-while-cp-rail-drops-amid-takeover-offer-for-kansas-city-southern.html”,”seoDescription”:”Stock surges and setback for the week ending March 26″,”publishedepoch”:1617015600000,”lastmodifiedepoch”:1616886129028,”abstractVisible”:false,”paywallMode”:”metered”,”storyuuid”:”accc43f3-c1ae-40fb-b32d-224b1544ef4c”,”republish”:true,”slideshowid”:”B881400174Z.1″,”lastmodified”:”03 27 2021″,”lastreplicated”:”7:00 AM, Mon., March 29, 2021″,”readtime”:2,”breadcrumbs”:[{“label”:”Business”,”relurl”:”/business”,”url”:”https://www.thestar.com/content/thestar/business.html”}],”authors”:[{“janrainUuid”:”2d1f9caf-acb1-4045-88f6-2d46c83d4983″,”author”:”Josh Rubin”,”facebookmeta”:”https://www.facebook.com/pages/Josh-Rubin/234914459966218″,”photo”:{“origImageSize”:”800×500″,”lastmodified”:2700061000,”url”:”/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”,”sizes”:{“1:1”:{“small”:”https://w6nnews.com/wp-content/uploads/2021/03/1616280733_270_The-Faceoff-Online-shopping-struggle-—-Shopify-is-luring-businesses.jpg”},”3:2″:{“small”:”https://images.thestar.com/nhAmckWnBcS988bkCf5BJKWX4nw=/114×76/smart/https://www.thestar.com/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”,”medium”:”https://images.thestar.com/VUGML7cxntQPnSJZYcLpzu9Q4OQ=/330×220/smart/https://www.thestar.com/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”,”large”:”https://images.thestar.com/iAjJqpo7K5ovzHFlQPEDHqFCmPg=/690×460/smart/https://www.thestar.com/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”},”21:9″:{“large”:”https://images.thestar.com/bgftfWvkqliNGkLDyB_LBeM_AVk=/1080×460/smart/https://www.thestar.com/content/dam/thestar/columnist_logos/Rubin_Josh_logo2015W.jpg”}}},”location”:”Toronto”,”tag”:”josh_rubin”,”credit”:”Business Reporter”,”twitterId”:”starbeer”,”email”:”josh@thestar.ca”}],”paywall”:true,”urlMetatag”:”https://www.thestar.com/business/2021/03/29/helius-medical-technologies-gets-boost-after-securing-fda-approval-while-cp-rail-drops-amid-takeover-offer-for-kansas-city-southern.html”,”numOfParagraphs”:13,”liftigImage”:{“captionPosition”:”overlay”,”fullWindowMainart”:false,”type”:”image”,”imageid”:”G0716FVBL.3″,”origImageSize”:”1200×801″,”lastmodified”:1616796441384,”forceoriginal”:false,”caption”:”Helius Medical Technologies had success this week after it was announced that its Portable Neuromodulation Stimulator, designed to help multiple sclerosis patients with their gait, received marketing approval by the U.S. Food and Drug Administration. It is already been approved for use in Canada.”,”source”:”Dreamstime”,”credit”:””,”url”:”/content/dam/thestar/business/2021/03/29/helius-medical-technologies-gets-boost-after-securing-fda-approval-while-cp-rail-drops-amid-takeover-offer-for-kansas-city-southern/woman_with_walker.jpg”,”mainartSize”:”medium”,”renditions”:[{“url”:”https://images.thestar.com/ADYKcuUBNsaOtnW9NGut9dtf3ew=/93×52/smart/filters:cb(1616796441384)/https://www.thestar.com/content/dam/thestar/business/2021/03/29/helius-medical-technologies-gets-boost-after-securing-fda-approval-while-cp-rail-drops-amid-takeover-offer-for-kansas-city-southern/woman_with_walker.jpg”,”width”:93,”height”:52,”scalefactor”:8,”aspect”:”wide”}]},”seopublisheddate”:”2021-03-29″,”seomodifieddate”:”2021-03-29T11:00:02.568Z”,”primarylabel”:{“label”:”Business”,”relurl”:”/business”,”url”:”https://www.thestar.com/content/thestar/business.html”},”totalParas”:0,”additionalEvents”:”,event29″}
//–>
ADVERTISEMENT
WINNERS
Andrew Peller Ltd. (ADW)
When this Niagara Region winery wanted to get a bigger piece of the wine tourism action, it didn’t have to look far. Late last month, Peller bought The Riverbend Inn and Vineyard in Niagara-on-the-Lake, in a deal worth $10 million. The Riverbend, which includes a 21-room hotel, restaurant and 17 acres of vineyards, is right across the street from the company’s flagship Peller Estates Winery, and 10 minutes drive from Wayne Gretzky Estates, the company’s partnership with the hockey legend.
George Weston Ltd. (WN)
The company behind the Loblaw empire announced this week it was looking to sell off its bakery division. The company also unveiled an executive suite reshuffling, announcing that Galen G. Weston will take over as chairman and president of the Loblaws grocery chain in early May, when current president Sarah Davis retires. Late last year, Weston also took over as controlling shareholder of Wittington Investments Ltd., the family’s holding company, succeeding his father W. Galen Weston.
Helius Medical Technologies (HSM)
The little-known Pennsylvania-based company, which trades on the TSX, announced last week that its Portable Neuromodulation Stimulator has received marketing approval by the U.S. Food and Drug Administration. The PoNS is designed to help multiple sclerosis patients with their gait, and has also been used to help patients with mild to moderate brain injuries maintain their balance. It’s Helius’s only commercially available product, and has already been approved for use in Canada.
LOSERS
Canaccord Genuity Group Inc.: Canaccord revealed last week that it had made a $367-million bid for fellow wealth management firm RF Capital Group, a move that was rejected out of hand by RF Capital’s board of directors and its biggest shareholder. That shareholder, Richardson Financial Group Ltd., wouldn’t even meet to discuss the offer, according to Canaccord. The takeover would have brought two of Canada’s biggest independent wealth management firms under the same roof.
Riv Capital Inc. (RIV)
Pity poor Riv. Ever since a deal to cut ties with its former parent company (licensed cannabis producer Canopy Growth) closed in late February, Riv’s shares have been mired in the doldrums. The cannabis-focused venture capital firm, which already has stakes in 13 different companies, has announced it will be pursuing more investments in the U.S. Riv is also one of several companies being sued for $500 million by a former partner in PharmHouse, a cannabis-growing joint venture that sought protection from creditors last year.
CP Rail (CP)
CP’s proposed takeover of U.S. rail firm Kansas City Southern would give the combined company a 37,000-kilometre network that ranges from Canada to Mexico. But the $25 billion (U.S.) deal could still get kiboshed by U.S. regulators, who haven’t approved a rail merger in 20 years. CP Rail investors could also be forgiven for being concerned about the company’s already sky-high debt ratio, which could climb even higher if the deal is approved.
Loading…
Loading…Loading…Loading…Loading…Loading…
More from The Star & Partners
.